美国 · 经济杂志 · Markets Insider (Business Insider)

Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform

来源：Markets Insider (Business Insider) · 美国 4 小时前

NANJING, China, Oct. 25, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (âLeads Biolabsâ, Stock Code: 9887.HK) today announced updated firstâinâhuman clinical…

在 Markets Insider (Business Insider) 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (markets.businessinsider.com)

Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform

推荐阅读

Your Lazy Weekend Might Be the Reason You’re So Tired on Monday

‘Everyone is hedging.’ As the U.S. and China divide the world into rival AI blocs, that lends power to ‘swing countries’ in between

Can a Roth Conversion Wait if You're 5-10 Years From Retiring?

Look up tonight: October’s full moon is for hunters

When A Health Challenge Changes How You Think About Work

How the conservative Supreme Court has rewritten the rules for the midterms

Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform

分享

推荐阅读

Your Lazy Weekend Might Be the Reason You’re So Tired on Monday

‘Everyone is hedging.’ As the U.S. and China divide the world into rival AI blocs, that lends power to ‘swing countries’ in between

Can a Roth Conversion Wait if You're 5-10 Years From Retiring?

Look up tonight: October’s full moon is for hunters

When A Health Challenge Changes How You Think About Work

How the conservative Supreme Court has rewritten the rules for the midterms